Associated Papers
Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma - results of a prospective cohort study.
Tupikowski K et al.
Archives of Medical Science : Ams, 2023
Predicting the functional consequences of genetic variants in co-stimulatory ligand B7-1 using in-silico approaches.
Mathur R et al.
Human Immunology, 2021
Mutational signatures and the genomic landscape of betel quid chewing-associated tongue carcinoma.
Zhang W et al.
Cancer Medicine, 2019
30672146 (PubMed )
Supplement: CAM4-8-701-s012.xlsx › Table_S11
Association of CD28 and CTLA4 haplotypes with susceptibility to primary Sjögren's syndrome in Mexican population.
López-Villalobos EF et al.
Journal of Clinical Laboratory Analysis, 2019
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.
Queirolo P et al.
Frontiers in Immunology, 2017
A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
Banelli B et al.
Human Immunology, 2014
The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
Torres-Carrillo N et al.
Cell Biochemistry and Biophysics, 2013
CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L et al.
Human Immunology, 2011
Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K et al.
Human Immunology, 2008
Select a paper to view details